Literature DB >> 24836662

Surgical strategies and outcomes of spinal ependymomas of different lengths: analysis of 210 patients: clinical article.

Teng-Yu Li1, Jun-Sheng Chu, Yu-Lun Xu, Jun Yang, James Wang, Yu-Hua Huang, Aij-Lie Kwan, Gui-Huai Wang.   

Abstract

OBJECT: The aim of this study was to investigate the surgical strategies and outcomes for spinal ependymomas of different lengths.
METHODS: The authors used data from 210 patients with spinal ependymomas (WHO Grades II and III) in this 10-year retrospective study (January 1999 to December 2008), dividing them into 3 different groups according to length (spinal ependymomas < 5 cm, 5-10 cm, and > 10 cm). All patients underwent tumor resection. The basic characteristics of the patients were reviewed and the functional status was assessed using the McCormick classification.
RESULTS: There were 89, 81, and 40 patients, respectively, in the 3 groups (< 5 cm, 5-10 cm, and > 10 cm). Grosstotal resections (GTRs) were performed in 172 patients (81.9% overall, or 86.5%, 79.0%, and 77.5% in the 3 groups, respectively). Subtotal and partial resections were achieved in 38 patients (18.1%). Eight patients with medulla oblongata or upper cervical cord tumors received a tracheotomy postoperatively. The follow-up period ranged from 56 to 176 months. One hundred thirty-five patients (76.7%) experienced improvement, (88.2%, 83.8%, and 34.4% in the < 5 cm, 5-10 cm, and > 10 cm groups, respectively). Thirty-three patients (18.8%) maintained their pretreatment status, and 8 patients (4.5%) showed deterioration following tumor resection at 6 months. Tumor recurrence or progression was observed in 6 (2.9%) of the 210 patients. Among the 6 patients, recurrent tumors were located in the conus (n = 3), thoracic (n = 1), and medullocervical cord (n = 2).
CONCLUSIONS: Radical resection of spinal ependymomas could be performed in most patients, and the rate of GTR was significantly different in the different-length groups (< 10 cm vs > 10 cm, p = 0.032). Patients with longer tumors had worse surgical results compared with those with small tumors (p < 0.001), and more postoperative neuropathic pain and proprioceptive deficits could usually be observed in patients harboring larger tumors. Early diagnosis and timely operation are critical to achieving better neurological outcomes. For tumors with dense adhesions, complete removal should be performed cautiously because of the significant incidence of neurological deterioration.

Entities:  

Keywords:  GTR = gross-total resection; SSEP = somatosensory evoked potential; STR = subtotal resection; ependymoma; mMEP = muscle motor evoked potential; oncology; prognosis; recurrence; spinal cord tumor

Mesh:

Year:  2014        PMID: 24836662     DOI: 10.3171/2014.3.SPINE13481

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  11 in total

1.  Natural history of intramedullary spinal cord ependymoma in patients preferring nonoperative treatment.

Authors:  Bedjan Behmanesh; Florian Gessler; Stephan Dützmann; Daniel Dubinski; Lioba Imoehl; Volker Seifert; Matthias Setzer; Gerhard Marquardt
Journal:  J Neurooncol       Date:  2017-06-30       Impact factor: 4.130

2.  Treatment strategy for multisegmental cervicomedullary ependymoma: illustrative case.

Authors:  Andrei A Zrelov; Malik M Tastanbekov; Mikhail V Alexandrov; Anastasiia S Nechaeva; Olga A Toporkova; Olga M Vorobeva; Konstantin A Samochernykh
Journal:  J Neurosurg Case Lessons       Date:  2021-12-20

3.  Analysis on therapeutic outcomes and prognostic factors of intracranial ependymoma: a report of 49 clinical cases in a single center.

Authors:  Jingliang Ye; Junle Zhu; Jiayi Yan; Peiqin Chen; Zhiping Wan; Feng Chen; Lei Zhang; Jun Qian; Chun Luo
Journal:  Neurol Sci       Date:  2015-07-28       Impact factor: 3.307

4.  Variety of preoperative MRI changes in spinal cord ependymoma of WHO grade II: a case series.

Authors:  Kazuyoshi Kobayashi; Kei Ando; Fumihiko Kato; Koji Sato; Mitsuhiro Kamiya; Mikito Tsushima; Masaaki Machino; Kyotaro Ota; Masayoshi Morozumi; Satoshi Tanaka; Shunsuke Kanbara; Sadayuki Ito; Naoki Ishiguro; Shiro Imagama
Journal:  Eur Spine J       Date:  2018-09-12       Impact factor: 3.134

5.  Grade III intradural extramedullary anaplastic ependymoma managed with near-complete resection and adjuvant radiotherapy: a case report.

Authors:  Satoshi Ando; Osahiko Tsuji; Narihito Nagoshi; Satoshi Nori; Satoshi Suzuki; Eijiro Okada; Mitsuru Yagi; Rie Irie; Kota Watanabe; Masaya Nakamura; Morio Matsumoto
Journal:  Spinal Cord Ser Cases       Date:  2021-01-19

6.  Surgical management of intradural spinal cord tumors in children and young adults: A single-center experience with 50 patients.

Authors:  Neriman Özkan; Ramazan Jabbarli; Karsten Henning Wrede; Zeynep Sariaslan; Klaus Peter Stein; Philipp Dammann; Adrian Ringelstein; Ulrich Sure; Erol Ibrahim Sandalcioglu
Journal:  Surg Neurol Int       Date:  2015-12-08

7.  Surgical outcome and prognostic factors in spinal cord ependymoma: a single-center, long-term follow-up study.

Authors:  Oliver Gembruch; Mehdi Chihi; Merle Haarmann; Ahmet Parlak; Marvin Darkwah Oppong; Laurèl Rauschenbach; Anna Michel; Ramazan Jabbarli; Yahya Ahmadipour; Ulrich Sure; Philipp Dammann; Neriman Özkan
Journal:  Ther Adv Neurol Disord       Date:  2021-11-10       Impact factor: 6.570

8.  Intraoperative application of yellow fluorescence in resection of intramedullary spinal canal ependymoma.

Authors:  Zhenxing Sun; Dan Yuan; Yaxing Sun; Yi Guo; Guoqin Wang; Peihai Zhang; James Wang; Wei Shi; Guihuai Wang
Journal:  J Int Med Res       Date:  2022-03       Impact factor: 1.671

9.  Fluorescence Guided Surgery with 5-Aminolevulinic Acid for Resection of Spinal Cord Ependymomas.

Authors:  Rafael García Moreno; Luis Miguel Bernal García; Hyaissa Ippolito Bastidas; Carlos Andrés Mondragón Tirado; Aurora Moreno Flores; Juan Pablo Sosa Cabezas; José Manuel Cabezudo Artero
Journal:  Asian Spine J       Date:  2018-10-24

10.  Microsurgical Resection of Brain Stem Ependymoma: 2-Dimensional Operative Video.

Authors:  Mirza Pojskić; Vincent Nguyen; Goran Lakičević; Kenan I Arnautović
Journal:  Oper Neurosurg (Hagerstown)       Date:  2020-06-01       Impact factor: 2.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.